Steven F Maier Selected Research

ATL 313

1/2019	A single peri-sciatic nerve administration of the adenosine 2A receptor agonist ATL313 produces long-lasting anti-allodynia and anti-inflammatory effects in male rats.
1/2018	Sustained reversal of central neuropathic pain induced by a single intrathecal injection of adenosine A2A receptor agonists.
10/2013	Intrathecal injection of adenosine 2A receptor agonists reversed neuropathic allodynia through protein kinase (PK)A/PKC signaling.
11/2009	Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven F Maier Research Topics

Disease

56	Pain (Aches) 01/2022 - 01/2003
54	Hyperalgesia 01/2022 - 12/2001
35	Neuralgia (Stump Neuralgia) 10/2022 - 02/2003
18	Shock 01/2021 - 01/2002
17	Infections 05/2018 - 02/2005
16	Inflammation (Inflammations) 01/2021 - 01/2004
11	Neuroinflammatory Diseases 10/2021 - 10/2011
6	Chronic Pain 11/2019 - 03/2005
4	Peripheral Nerve Injuries 01/2022 - 11/2008
4	Memory Disorders (Memory Loss) 01/2021 - 10/2004
4	Wounds and Injuries (Trauma) 01/2017 - 11/2012
4	Fever (Fevers) 10/2011 - 02/2003
4	Bacterial Infections (Bacterial Infection) 08/2011 - 04/2008
4	Opioid-Related Disorders (Opiate Addiction) 01/2010 - 02/2007
3	Postoperative Cognitive Complications 01/2023 - 10/2012
3	Cognitive Dysfunction 01/2023 - 08/2011
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 01/2017
3	Contusions 01/2019 - 01/2017
3	Migraine Disorders (Migraine) 01/2017 - 01/2012
3	Escherichia coli Infections 01/2015 - 02/2010
3	AIDS-Related Complex (ARC) 08/2012 - 01/2010
3	Respiratory Insufficiency (Respiratory Failure) 01/2010 - 11/2008
2	Brain Diseases (Brain Disorder) 01/2021 - 05/2015
2	Hypersensitivity (Allergy) 11/2019 - 03/2015
2	Obesity 10/2017 - 11/2014
2	Mood Disorders (Mood Disorder) 01/2017 - 11/2003
2	Substance-Related Disorders (Drug Abuse) 01/2015 - 06/2011
2	Peripheral Nervous System Diseases (PNS Diseases) 11/2012 - 07/2007

Drug/Important Bio-Agent (IBA)

49	CytokinesIBA 01/2022 - 01/2003
23	Morphine (MS Contin)FDA LinkGeneric 01/2023 - 01/2002
18	Opioid Analgesics (Opioids)IBA 01/2021 - 12/2005
16	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2005
14	Toll-Like Receptor 4IBA 01/2021 - 07/2008
13	Interleukin-1 (Interleukin 1)IBA 08/2017 - 02/2003
11	Interleukin-10 (Interleukin 10)IBA 01/2019 - 03/2004
10	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2023 - 10/2004
9	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021 - 03/2004
8	Interleukin-6 (Interleukin 6)IBA 01/2021 - 02/2003
8	Messenger RNA (mRNA)IBA 01/2021 - 10/2004
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 02/2003
8	LipopolysaccharidesIBA 02/2015 - 08/2005
8	Interleukin-1beta (Interleukin 1 beta)IBA 11/2014 - 11/2003
7	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 02/2002
7	Analgesics (Analgesic Drugs)IBA 09/2011 - 08/2004
6	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023 - 11/2007
6	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2012 - 08/2004
5	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 11/2009
5	InflammasomesIBA 01/2018 - 08/2015
5	HMGB1 Protein (HMG1)IBA 01/2018 - 12/2003
5	Minocycline (Cyclops)FDA LinkGeneric 01/2017 - 05/2005
5	ChemokinesIBA 01/2017 - 08/2004
5	CorticosteroneIBA 10/2011 - 02/2003
4	Neutralizing AntibodiesIBA 01/2022 - 03/2004
4	Naltrexone (ReVia)FDA LinkGeneric 01/2021 - 07/2008
4	ATL 313IBA 01/2019 - 11/2009
4	salicylhydroxamic acid (SHAM)IBA 01/2019 - 11/2009
4	GlucocorticoidsIBA 11/2018 - 06/2011
4	Dinoprostone (PGE2)FDA Link 01/2017 - 01/2010
3	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2023 - 01/2017
3	NLR ProteinsIBA 01/2022 - 01/2016
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2021
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 03/2004
3	BradykininIBA 01/2017 - 01/2010
3	ibudilastIBA 01/2017 - 02/2009
3	Histamine (Histamine Dihydrochloride)FDA Link 01/2017 - 01/2010
3	Ethanol (Ethyl Alcohol)IBA 08/2015 - 05/2013
3	Freund's AdjuvantIBA 02/2014 - 01/2012
3	Formaldehyde (Formol)FDA Link 02/2014 - 10/2010
3	Naloxone (Narcan)FDA LinkGeneric 05/2012 - 07/2008
3	Glycoproteins (Glycoprotein)IBA 01/2010 - 10/2005
2	Superoxides (Superoxide)IBA 10/2022 - 12/2016
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 10/2021 - 01/2018
2	Toll-Like Receptor 2IBA 01/2021 - 05/2012
2	Opioid Receptors (Opioid Receptor)IBA 01/2021 - 11/2009
2	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 11/2007
2	NF-kappa B (NF-kB)IBA 01/2019 - 10/2005
2	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 01/2018 - 11/2009
2	LigandsIBA 01/2018 - 01/2017
2	Neurotransmitter Agents (Neurotransmitter)IBA 12/2016 - 03/2007
2	morphine-3-glucuronideIBA 02/2015 - 05/2013
2	GlucuronidesIBA 02/2015 - 05/2013
2	ethyl glucuronideIBA 02/2015 - 05/2013
2	alpha7 Nicotinic Acetylcholine ReceptorIBA 12/2012 - 08/2010
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2012 - 08/2010
2	Narcotic Antagonists (Opioid Antagonists)IBA 05/2012 - 07/2008
2	Glutamic Acid (Glutamate)FDA Link 09/2011 - 07/2004
2	AntibodiesIBA 08/2010 - 11/2009
2	DNA (Deoxyribonucleic Acid)IBA 07/2007 - 12/2006

Therapy/Procedure

16	Therapeutics 01/2022 - 07/2004
11	Spinal Injections 01/2022 - 03/2005
11	Analgesia 12/2016 - 08/2004
4	Laparotomy 01/2019 - 10/2010
3	Operative Surgical Procedures 01/2023 - 01/2004
3	Subcutaneous Injections 01/2012 - 03/2004
3	Injections 01/2012 - 12/2003
2	Behavior Control 06/2019 - 09/2012
2	Catheters 01/2017 - 01/2012
2	Pain Management 01/2016 - 04/2015
2	Ligation 10/2013 - 05/2012